Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis
Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved..
The development and commercialization of glucose sensors and insulin pumps has revolutionized the management of diabetes. These devices have been linked to multiple cases of contact dermatitis in recent years, however, giving rise to a growing interest in identifying the sensitizing allergens. Isobornyl acrylate was clearly identified as one of the main allergens responsible for contact dermatitis among users of the FreeStyle glucose sensor and was subsequently removed from the product ingredients. Remarkably, however, it is still used in most other sensors on the market. The common adhesive ingredients colophony and abietic acid derivatives have also been shown to be sensitizing agents. New components under study, such as dipropylene glycol diacrylate, N,N-dimethylacrylamide, and triethylene glycol methacrylate have recently been identified as allergens, though they are not commercially available for clinical testing. The benefits offered by glucose sensors and insulin pumps may be offset by sensitization to product ingredients, in some cases forcing discontinuation and diminishing quality of life. Dermatologists should play a role in this clinical and research scenario, offering case-by-case guidance to endocrinologists on skin care and possible alternatives for patients with glucose sensors and insulin pumps who develop contact dermatitis. They should also collaborate with the manufacturers developing these devices.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:115 |
|---|---|
| Enthalten in: |
Actas dermo-sifiliograficas - 115(2024), 3 vom: 31. März, Seite T280-T287 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Velasco-Amador, J P [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.03.2024 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ad.2024.01.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367329263 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367329263 | ||
| 003 | DE-627 | ||
| 005 | 20240312233622.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240120s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ad.2024.01.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM367329263 | ||
| 035 | |a (NLM)38242434 | ||
| 035 | |a (PII)S0001-7310(24)00032-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Velasco-Amador, J P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.03.2024 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a The development and commercialization of glucose sensors and insulin pumps has revolutionized the management of diabetes. These devices have been linked to multiple cases of contact dermatitis in recent years, however, giving rise to a growing interest in identifying the sensitizing allergens. Isobornyl acrylate was clearly identified as one of the main allergens responsible for contact dermatitis among users of the FreeStyle glucose sensor and was subsequently removed from the product ingredients. Remarkably, however, it is still used in most other sensors on the market. The common adhesive ingredients colophony and abietic acid derivatives have also been shown to be sensitizing agents. New components under study, such as dipropylene glycol diacrylate, N,N-dimethylacrylamide, and triethylene glycol methacrylate have recently been identified as allergens, though they are not commercially available for clinical testing. The benefits offered by glucose sensors and insulin pumps may be offset by sensitization to product ingredients, in some cases forcing discontinuation and diminishing quality of life. Dermatologists should play a role in this clinical and research scenario, offering case-by-case guidance to endocrinologists on skin care and possible alternatives for patients with glucose sensors and insulin pumps who develop contact dermatitis. They should also collaborate with the manufacturers developing these devices | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Allergens | |
| 650 | 4 | |a Alérgenos | |
| 650 | 4 | |a Bombas de insulina | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Dispositivos médicos | |
| 650 | 4 | |a Glucose sensor | |
| 650 | 4 | |a Insulin pumps | |
| 650 | 4 | |a Medical devices | |
| 650 | 4 | |a Patch tests | |
| 650 | 4 | |a Pruebas epicutáneas | |
| 650 | 4 | |a Sensibilización | |
| 650 | 4 | |a Sensitization | |
| 650 | 4 | |a Sensor de glucosa | |
| 650 | 7 | |a Acrylates |2 NLM | |
| 650 | 7 | |a Allergens |2 NLM | |
| 650 | 7 | |a Glucose |2 NLM | |
| 650 | 7 | |a IY9XDZ35W2 |2 NLM | |
| 650 | 7 | |a Insulins |2 NLM | |
| 700 | 1 | |a Prados-Carmona, Á |e verfasserin |4 aut | |
| 700 | 1 | |a Navarro-Triviño, F J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Actas dermo-sifiliograficas |d 1945 |g 115(2024), 3 vom: 31. März, Seite T280-T287 |w (DE-627)NLM000271438 |x 1578-2190 |7 nnns |
| 773 | 1 | 8 | |g volume:115 |g year:2024 |g number:3 |g day:31 |g month:03 |g pages:T280-T287 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ad.2024.01.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 115 |j 2024 |e 3 |b 31 |c 03 |h T280-T287 | ||